cistanche_enjoyer

For those of you who are parents (or want to become parents), what did you take into account when making this decision? Are kids a distraction from spiritual work? But also, aren’t kids like an “investment” for when you become older (they can take care of you, be a companion, especially if you manage to build a good relationship with them)?

I think it depends on your current health status and genetics. Some healthy people may do fine on a vegan diet if coupled with appropriate supplementation. But most people nowadays have some sort of chronic health issue, simply due to living in the modern world (pollution, heavy metals, microplastics, electromagnetic radiation, etc.). In this case, consuming animal products like eggs, grass-fed beef, liver, milk, cheese, etc. will provide lots of essential nutrients that are necessary for optimal health (vegan foods don’t come nowhere near in terms of quality/quantity/bioavailability of nutrients). In the end, for seeking truth, you want your health to be optimal so your mind can be sharp and focused on truth. If this implies eating animal products, so be it.

Why? What do you think you will get out of having kids?

For a healthy young male with a high sex drive, what is the optimal frequency of ejaculation? Too much and it drains you of your vitality, but if you try to repress it, it can also backfire. Have you tried experimenting in this regard?

Actually I’d say genetics plays even a bigger role - as with almost everything when it comes to physical health and performance

Using your analogy for the scale of consciousness, from 2-3 (normal humans) to infinity, where would you consider your current level to be?

Btw I just realized I posted this in the wrong forum section, can a mod please move it to “Psychedelics”?

I did a deep research using the OpenAI o3 model, and found some very interesting results: Drawing together the threads of evidence, we can attempt a reasoned assessment of how psilocybin and related classic psychedelics might influence overall health and longevity – weighing their remarkable benefits against theoretical and observed risks, from first principles of biology and current empirical data. Documented Benefits: Classic psychedelics offer a multifaceted suite of potential health benefits. Psychologically, they can deliver rapid and enduring relief from depression, anxiety, and trauma-related distress, often succeeding where conventional treatments fail . This is not just about feeling better – chronic depression and anxiety have well-known negative effects on physical health and lifespan (for instance, via elevated stress hormones, inflammation, and poor health behaviors) . By effectively treating these conditions, psychedelics might indirectly improve longevity – a happier, less stressed brain sends healthier signals to the body (lower cortisol, better immune function). Population data showing lower rates of hypertension, heart disease, and substance abuse among psychedelic users support the idea that improved mental health and lifestyle after psychedelic experiences can translate into tangible physical health advantages. Furthermore, at the cellular level, psilocybin has now been shown to engage anti-aging pathways: it boosts SIRT1, preserves telomeres, reduces oxidative stress, and delays cellular senescence . These are precisely the kind of effects one would want from a longevity-promoting drug. In aged mice, psilocybin improved survival and signs of vitality (like coat health) , suggesting a systemic rejuvenating influence – possibly by reducing chronic inflammation and enhancing stress resilience in tissues. Psychedelics also potently promote neuroplasticity, which could help maintain cognitive function into older age. Imagine if periodic psychedelic therapy in midlife helped prevent or slow neurodegenerative changes by sprouting new neural connections and reducing neuroinflammation; this is speculative but not implausible given current knowledge. Even microdosing might offer subtle hormetic benefits: a low-dose psychedelic might gently stimulate cellular defenses (e.g. that small TNF-α burst in resting macrophages followed by anti-inflammatory effects could be viewed as a hormetic conditioning of the immune system). The fact that psychedelics can act as anti-inflammatory agents in the context of illness is significant, because chronic low-grade inflammation is a hallmark of aging (“inflammaging”). If carefully harnessed, psychedelics could reduce this burden – for instance, a guided psychedelic session might reset inflammatory cytokine networks or epigenetic markers in immune cells, leading to a more youth-like immune profile. Another angle: psychedelics often lead to profound existential or spiritual insights, including a sense of interconnectedness and personal meaning. Such positive shifts in psychosocial well-being are associated with longevity. Studies on longevity have found that strong social bonds, a sense of purpose, and stress reduction correlate with longer lifespan. Psychedelics rather uniquely can facilitate feelings of unity, meaning, and awe – experiences that can permanently enrich one’s life perspective. Users often describe being more engaged with life, more open to others, and more appreciative of each day after a psychedelic experience. In principle, this could encourage healthier behavior (diet, exercise, relationships) and reduce risk factors over time . Indeed, quitting harmful habits (smoking, excessive drinking) after psychedelic therapy has been documented and would directly improve health outcomes. On the cognitive front, maintaining neuroplasticity and cognitive flexibility into older age is crucial for longevity (cognitively sharp individuals tend to live longer and more independently). Psychedelics’ plasticity effect – especially if periodic macrodoses or ongoing microdoses can be given safely – might act as a “mental fertilizer,” promoting learning, memory, and adaptation in the aging brain. Some scientists even speculate about microdosing as a cognitive enhancer for middle-aged or older adults to help with age-related cognitive decline (though this is far from proven). Theoretical and Observed Risks: The most concrete physiological risk identified is the cardiac valvulopathy concern with chronic use (especially microdosing) . From first principles, we know 5-HT₂B activation can lead to fibrotic changes – it happened with fenfluramine and certain ergolines taken daily for long periods. Psychedelics do hit the 5-HT₂B receptor. Although thus far no valvular heart disease has been reported in psychedelic research volunteers or users, microdosing as a widespread practice is relatively new and typically done outside medical monitoring. If one were to microdose continuously for years, in theory they could be slowly thickening their heart valves. The risk might be low – psychedelics are not as potent at 5-HT₂B as fenfluramine was, and microdose blood levels are much lower – but it cannot be dismissed. Therefore, from a longevity standpoint, routine daily microdosing is not risk-free for the heart. A prudent approach might be microdosing in “cycles” (with breaks) or focusing on substances like mescaline (which has negligible 5-HT₂B effect) if one chooses to microdose, though mescaline’s higher effective dose makes it less practical. Another risk: psychiatric stability. While classic psychedelics are non-addictive, a bad macrodose experience can be acutely stressful – potentially dangerous for those with unstable heart or aneurysms – and could leave psychological scars (e.g. persistent anxiety or HPPD symptoms) in rare cases. These are typically avoidable with proper screening and setting, but they are risks to consider when advocating any widespread use. We must also note the regulatory and legal issues – currently, these substances are controlled in many countries, which means using them (especially unsupervised) carries legal risk and variability in drug purity, etc. From a pure health perspective, that’s not a biological risk but it does impact the risk-benefit calculus for an individual considering use. A more subtle risk is the unknown long-term effect on neurotransmitter systems. Chronic microdosing could possibly lead to alterations in serotonin receptor density or sensitivity. If someone stopped after years of microdosing, would their mood dip or would there be any withdrawal-like adjustment? We don’t have data. However, given that even daily microdosing results in tolerance (meaning receptors downregulate somewhat), it’s plausible there could be a period of readjustment if one stops (maybe a temporary slump in mood or energy as serotonin systems normalize). This would need to be studied, but compared to the withdrawal from many chronic medications (e.g. benzodiazepines, SSRIs, etc.), any microdosing cessation effects would likely be mild since psychedelics don’t produce dependency. From first-principles reasoning, one might also wonder: Could stimulating so much neuroplasticity be a double-edged sword? There’s an oft-cited line: “neurons that fire together, wire together.” Psychedelics indiscriminately increase neural connectivity and plasticity for a window of time. If used properly, therapy directs this toward positive rewiring (e.g. extinguishing fear memories, creating positive associations). But if used in a chaotic or negative environment, is there a risk of wiring in some maladaptive patterns? Perhaps – for example, someone who takes a psychedelic in a bad setting could potentially reinforce traumatic pathways instead of healing them, if they experience terror without support. While speculative, this reminds us that set and setting are crucial for beneficial outcomes. For health optimization, one should ensure that psychedelic use (macro or micro) is accompanied by positive context, intention, and integration, to channel the plasticity toward beneficial ends. Risk-Benefit Balance: For macrodose therapeutic use in controlled settings for those who need it (e.g. a 50-year-old with severe depression or an addiction), the benefits can be life-saving and transformative, clearly outweighing the relatively small medical risks (transient blood pressure rise, etc.) as evidenced by clinical trial results and safety monitoring. For such individuals, a psychedelic therapy could not only improve quality of life but potentially extend life by resolving conditions that would have shortened it (depression raises risk of mortality through suicide and illness, addiction obviously impacts longevity; treating these is a huge benefit). In these cases, careful medical oversight mitigates acute risks, and frequency of dosing is low (one to a few sessions), so long-term physical risks are minimal. Thus, therapeutic macrodosing under guidance has an excellent benefit-risk ratio. For microdosing by healthy individuals aiming for performance or longevity enhancement, the calculus is more nuanced. The potential benefits (mild mood elevation, possibly reduced inflammation, maybe cognitive nimbleness) are subtler and not yet conclusively proven, whereas the risks (like valvulopathy) are theoretical but could manifest silently. In a healthy person who doesn’t need a psychedelic intervention, one must ask: do the subtle benefits justify even a remote chance of heart valve damage? If the risk is extremely low and the person is properly informed, some might decide it’s worth it for enhanced creativity or mood. Others might choose to wait for more research. It could be that microdosing once or twice a week for a few months is virtually harmless and provides a nice boost, but microdosing daily for years might accumulate risk. From a longevity strategy perspective, one might lean toward occasional macrodose journeys (perhaps once a year or a few times in a lifetime) in a safe setting as “checkpoints” to realign mental health and reduce stress – this could yield many of the psychological benefits we’ve discussed without continuous drug exposure. Meanwhile, one could avoid heavy continuous microdosing until more is known, or keep microdosing to a conservative schedule (e.g. a few weeks on, then many weeks off) to allow the body to reset. This way, you get perhaps the best of both – periodic big neuroplastic/anti-depressant boosts, with minimal physical downsides. It’s also important to highlight that classic psychedelics do not appear to negatively affect major organ systems like the liver, kidneys, or bone marrow, even with repeated use – a significant plus compared to many pharmaceuticals. They are also not associated with cognitive decline; if anything, they trend toward cognitive enhancement and protective factors. They are non-toxic (the lethal dose for psilocybin or LSD is astronomically high relative to an active dose, virtually impossible to reach in practice, unlike many medications or substances such as alcohol). This intrinsic safety (physically) is one reason researchers are excited about using them in medicine. The main risks come from psychological effects and the 5-HT₂B issue for chronic use. Conclusion: When weighing all factors, the overall benefits of psilocybin and related psychedelics for health and longevity appear to outweigh the risks, provided they are used in a conscientious, controlled manner. Classic psychedelics present a unique convergence of mental health therapy and potential physiological anti-aging effects – a convergence rarely seen in other compounds. By dramatically improving mood and reducing maladaptive behaviors, they tackle “soft” factors that strongly influence longevity (since mental and emotional well-being are linked to better cardiovascular health, immune function, etc.). Simultaneously, early evidence shows they directly trigger cellular pathways of rejuvenation (telomere preservation, oxidative stress reduction) . This combination could make them powerful allies in a holistic longevity regimen.

“At the cellular level, psilocybin has now been shown to engage anti-aging pathways: it boosts SIRT1, preserves telomeres, reduces oxidative stress, and delays cellular senescence . These are precisely the kind of effects one would want from a longevity-promoting drug. In aged mice, psilocybin improved survival and signs of vitality (like coat health) , suggesting a systemic rejuvenating influence – possibly by reducing chronic inflammation and enhancing stress resilience in tissues. Psychedelics also potently promote neuroplasticity, which could help maintain cognitive function into older age. Imagine if periodic psychedelic therapy in midlife helped prevent or slow neurodegenerative changes by sprouting new neural connections and reducing neuroinflammation; this is speculative but not implausible given current knowledge.” Even Bryan Johnson is considering taking mushrooms now https://x.com/bryan_johnson/status/1943824432419811437?s=46

But what about transmuting this energy for other purposes, like spirituality or business?

I can’t understand how so many people use it as a party drug lol

Recently xAI upgraded Grok, and it started talking antisemitic stuff, for example see attached image. They were then forced to remove those posts and are currently working on “fixing” grok.

When you look at porn you are looking at God right? As long as it’s not an addiction, you can see it as exploring the infinite Beauty of God.

Exactly, if we suppose that it’s true what they say about the j*ws (and I have no idea if it’s true), any smart enough AI would figure it out. But if they attempt to censor it, won’t it also limit the intelligence of the AI?

Leo has said several times that he is dealing with health issues; still, he seems to maintain a high state of consciousness. How is this possible?

Leo, what about the feminine path to enlightenment? The one based on devotion and opening the heart chakra? The following video explains it pretty well, and gives an example of a woman who awakened via this path:

Is it simply genetics? I’m talking about people like Donald Trump, John Mcafee, the Rock, etc. in the celebrity realm. And even my Uncle My Uncle smokes 20 cigarettes a day, drinks probably 250 ml whiskey daily, and he has been doing it for 40 years. He sleeps only for like 5 hours. He’s now 60, and he has remarkable energy levels. He’s active for like 16-18 hours a day, no joke. Also I’ve literally never seen him fall sick. Not even once. All he eats is junk food Mcafee has said during his days building the antivirus software, he would go days without sleep. He did so even during his 70s, RIP Trump, who is almost 80 years old, apparently never exercises, sleeps only 3-4 hours a day on average, never drinks water, 12 diet cokes a day, highly processed food diet. All of this has been confirmed by Dana White, and many others. Sometimes he doesn’t sleep for 2-3 days even. Even his medical records are immaculate. Though he has said he’s never smoked or had alcohol. Despite all this, he seems to have an amazing level of energy, to get everything done. Is it possible to achieve this power?

Yes, but these other factors, even if they account for only 1% compared to genetics, can still have significant implications. Maybe you’re a bit self-biased if you have really bad genetics, but for people with regular genetics, improving the diet, taking targeted supplements, detoxing, having a proper social life, etc. can still have a huge impact. Didn’t you have periods in life when you had more energy? What do you think caused it?

Does anyone have experiences with this organization? Apparently this Vishwananda is God-realized and during his darshans he is able to “transfer” his energy to disciples, kinda like shaktipat.

Why isn’t this studied more? Couldn’t this be somehow recreated with supplements, or some advanced genetic therapy?

Joe Dispenza talks a lot about genes and how it’s possible to change them and their expressions. Accordingly, many people have healed incurable diseases like a miracle by following his methods. What do you think of him?

Is it simply because once you fully experience God's Love, any other lower type of love pales in comparison? Are human (romantic) relationships ultimately an obstacle to God?

Thanks, I love you Leo